Tcg Crossover Management, LLC Nektar Therapeutics Transaction History
Tcg Crossover Management, LLC
- $771 Million
- Q3 2024
A detailed history of Tcg Crossover Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 4,000,000 shares of NKTR stock, worth $4 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
4,000,000
Previous 4,000,000
-0.0%
Holding current value
$4 Million
Previous $4.96 Million
4.84%
% of portfolio
0.67%
Previous 0.74%
Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
146Shares Held
139MCall Options Held
32.6KPut Options Held
14.1K-
Deep Track Capital, LP Greenwich, CT15.9MShares$15.9 Million0.76% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$13.1 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA9.4MShares$9.4 Million0.22% of portfolio
-
Samlyn Capital, LLC New York, NY9.2MShares$9.2 Million0.19% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $187M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...